Key stats
About TIMEFOLIO TIMEFOLIO Kbio Active ETF Units
Home page
Inception date
Aug 17, 2023
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
TIMEFOLIO Asset Management Co., Ltd.
Identifiers
2
ISINKR7463050005
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.30%
Health Technology93.69%
Commercial Services4.25%
Health Services0.36%
Bonds, Cash & Other1.70%
Miscellaneous1.18%
Cash0.53%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
463050 invests in stocks. The fund's major sectors are Health Technology, with 93.69% stocks, and Commercial Services, with 4.25% of the basket. The assets are mostly located in the Asia region.
463050 top holdings are ABL Bio, Inc. and ALTEOGEN Inc., occupying 18.14% and 13.35% of the portfolio correspondingly.
No, 463050 doesn't pay dividends to its holders.
463050 shares are issued by TIMEFOLIO Asset Management Co., Ltd. under the brand Timefolio. The ETF was launched on Aug 17, 2023, and its management style is Active.
463050 expense ratio is 0.80% meaning you'd have to pay 0.80% of your investment to help manage the fund.
463050 follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
463050 invests in stocks.